Home > Products > CD3 & THY1 > Recombinant Anti-CD3 x Anti-THY1 Bispecific Antibody (Diabody-CH3)

Recombinant Anti-CD3 x Anti-THY1 Bispecific Antibody (Diabody-CH3)  (BSDBC-105)

Recombinant Anti-CD3 x Anti-THY1 Bispecific Antibody (Diabody-CH3) is a fusion protein of two diabodies connected together by a CH3 region. In a diabody, the two scFvs with short linkers are from anti-CD3 and anti-THY1 antibodies. The VH and VL domains form an inter-chain pairing. The diabody with different specificities is fused to each of the CH3 chains, which results in 2+2 antigen-binding valency and extends the half-life of this BsAb. This BsAb can retarget T cells to tumor cells. It is designed for the research of Leukemia therapy.

Specifications

Targets
CD3 & THY1
Type
Constant Domain-extended Bispecific Fragments
Species Reactivity
Human
Target 1
CD3
Host Animal 1
Mouse
Target 2
THY1
Host Animal 2
Mouse
Application
FuncS; Promising therapeutic agent
Related Disease
Leukemia

Targets

Target 1
CD3
Gene ID
UniProt ID
Alternative Names
CD3; CD3E; CD3e molecule; Cluster of differentiation 3; CD3e molecule, epsilon (CD3-TCR complex); T3E; TCRE; IMD18; T-cell surface glycoprotein CD3 epsilon chain; CD3-epsilon; T-cell surface antigen T3/Leu-4 epsilon chain; CD3e antigen, epsilon polypeptide (TiT3 complex); T-cell antigen receptor complex, epsilon subunit of T3
Target 2
THY1
Gene ID
UniProt ID
Alternative Names
CD90; CDw90; THY1; Thy-1 cell surface antigen

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-CD3 x Anti-THY1 Bispecific Antibody (Diabody-CH3) (BSDBC-105). Click the button below to contact us or submit your feedback about this product.

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Welcome! For price inquiries, we will get back to you as soon as possible.

To order, please email

INQUIRY
Related products of "CD3 & THY1"
Online Inquiry

24x7 Service quality
USA

Tel:
Fax:
Email:

UK

Tel:
Email:

Germany

Tel:
Email: